Clinical trial
Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for…
NCT00053716 · Endovasc, Industry · Unknown status
Key facts
| NCT number | NCT00053716 |
|---|---|
| Title | Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive Disease |
| Official title | Phase II, Single Center, Non-Controlled, Open-Label Study of Liposomal Prostaglandin E1 (Liprostin) as Adjunct Therapy With Lower Limb Angioplasty in Patients With Ischemic and Non-Ischemic Peripheral Arterial Occlusive Disease |
| Lead sponsor | Endovasc, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Peripheral Vascular Disease |
| Intervention type | Drug |
| Interventions | Liprostin [liposomal Prostaglandin E1] |
| Enrollment | 12 |
| Start date | Feb 1, 2003 |
| Completion | Aug 1, 2003 |
| First posted | Feb 6, 2003 |
| Last update posted | Mar 7, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: